GEN vs PHAT · P/E 17, rev $5.00B vs rev $55.3M
Gen Digital Inc. (GEN) versus Phathom Pharmaceuticals Inc (PHAT) — a side-by-side from cached financials, not a winner call.
Gen Digital Inc. (GEN) is a software - infrastructure company listed on US.
Phathom Pharmaceuticals Inc (PHAT) is a biotechnology company listed on US.
Latest reported GEN revenue for 2026-04-03 was $5.00B. Net income was $973.0M. Revenue was up 27.1% from 2025-03-28 to 2026-04-03. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
Latest reported PHAT revenue for 2024-12-31 was $55.3M. Net income was -$334.3M. Revenue was up 8001.5% from 2023-12-31 to 2024-12-31. PHAT currently screens at market cap $622.7M.
GEN currently screens at market cap $15.83B and trailing P/E 16.7. PHAT currently screens at market cap $622.7M.
Not investment advice. Open the GEN and PHAT stock pages for the full models.
Not investment advice.